{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T07:16:31Z","timestamp":1789370191442,"version":"build-2803163510"},"reference-count":143,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["K01ES019909"],"award-info":[{"award-number":["K01ES019909"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Department of Veterans Affairs, Veterans Health Administration"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Rheumatology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.berh.2016.05.002","type":"journal-article","created":{"date-parts":[[2016,6,26]],"date-time":"2016-06-26T09:59:23Z","timestamp":1466935163000},"page":"63-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Pregnancy and autoimmune connective tissue diseases"],"prefix":"10.1016","volume":"30","author":[{"given":"Wendy","family":"Marder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily A.","family":"Littlejohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily C.","family":"Somers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.berh.2016.05.002_bib1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jaut.2009.09.008","article-title":"Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases","volume":"33","author":"Cooper","year":"2009","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.berh.2016.05.002_bib2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/01.AOG.0000194205.95870.86","article-title":"Early risk factors for pregnancy loss in lupus","volume":"107","author":"Clowse","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.berh.2016.05.002_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajog.2008.03.012","article-title":"A\u00a0national study of the complications of lupus in pregnancy","volume":"199","author":"Clowse","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.berh.2016.05.002_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2393-9-11","article-title":"Elevated antiphospholipid antibody titers and adverse pregnancy outcomes: analysis of a population-based hospital dataset","volume":"9","author":"Nodler","year":"2009","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.berh.2016.05.002_bib5","first-page":"1709","article-title":"Decrease in pregnancy loss rates in patients with systemic lupus erythematosus over a 40-year period","volume":"32","author":"Clark","year":"2005","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2016.05.002_bib6","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/art.20864","article-title":"The impact of increased lupus activity on obstetric outcomes","volume":"52","author":"Clowse","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"Suppl. 1","key":"10.1016\/j.berh.2016.05.002_bib7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/rheumatology\/XXVIII.suppl_1.33","article-title":"The relationship between rheumatoid arthritis and reproductive function","volume":"28","author":"Del Junco","year":"1989","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.berh.2016.05.002_bib8","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1002\/art.1780331203","article-title":"Pregnancy and the risk of developing rheumatoid arthritis","volume":"33","author":"Hazes","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.05.002_bib9","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/art.1780330604","article-title":"The pill, parity, and rheumatoid arthritis","volume":"33","author":"Spector","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.05.002_bib10","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1002\/art.27459","article-title":"Does pregnancy provide vaccine-like protection against rheumatoid arthritis?","volume":"62","author":"Guthrie","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.05.002_bib11","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/ard.2008.099945","article-title":"National cohort study of reproductive risk factors for rheumatoid arthritis in Denmark: a role for hyperemesis, gestational hypertension and pre-eclampsia?","volume":"69","author":"J\u00f8rgensen","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2016.05.002_bib12","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00001648-199007000-00005","article-title":"Reproductive factors, smoking, and the risk for rheumatoid arthritis","volume":"1","author":"Hern\u00e1ndez Avila","year":"1990","journal-title":"Epidemiology"},{"key":"10.1016\/j.berh.2016.05.002_bib13","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1002\/art.20621","article-title":"Do breast-feeding and other reproductive factors influence future risk of rheumatoid arthritis? Results from the Nurses' Health Study","volume":"50","author":"Karlson","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.05.002_bib14","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/rheumatology\/34.7.625","article-title":"Parity and risk of rheumatoid arthritis in Finnish women","volume":"34","author":"Heli\u00f6vaara","year":"1995","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.berh.2016.05.002_bib15","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/rheumatology\/34.6.542","article-title":"Breast feeding, other reproductive factors and rheumatoid arthritis. A prospective study","volume":"34","author":"Brun","year":"1995","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.berh.2016.05.002_bib16","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0049-0172(03)00084-2","article-title":"Estrogen and other female reproductive risk factors are not strongly associated with the development of rheumatoid arthritis in elderly women","volume":"33","author":"Merlino","year":"2003","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.05.002_bib17","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/BOR.0000000000000047","article-title":"Is pregnancy a risk factor for rheumatic autoimmune diseases?","volume":"26","author":"Marder","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.berh.2016.05.002_bib18","doi-asserted-by":"crossref","first-page":"e19658","DOI":"10.1371\/journal.pone.0019658","article-title":"Pregnancy and the risk of autoimmune disease","volume":"6","author":"Khashan","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.berh.2016.05.002_bib19","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/ard.12.3.227","article-title":"Effect of pregnancy on the onset and course of rheumatoid arthritis","volume":"12","author":"Oka","year":"1953","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2016.05.002_bib20","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/art.1780350205","article-title":"Timing of pregnancy in relation to the onset of rheumatoid arthritis","volume":"35","author":"Silman","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.05.002_bib21","first-page":"171","article-title":"The onset of rheumatoid arthritis in relation to pregnancy and childbirth","volume":"11","author":"Lansink","year":"1993","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.berh.2016.05.002_bib22","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1289\/ehp.11092","article-title":"Recent advances and opportunities in research on lupus: environmental influences and mechanisms of disease","volume":"116","author":"Cooper","year":"2008","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.berh.2016.05.002_bib23","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/art.22683","article-title":"Incidence of systemic lupus erythematosus in the United Kingdom, 1990-1999","volume":"57","author":"Somers","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.05.002_bib24","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/art.38238","article-title":"Population-based incidence and prevalence of systemic lupus erythematosus: the Michigan Lupus Epidemiology and Surveillance program","volume":"66","author":"Somers","year":"2014","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"key":"10.1016\/j.berh.2016.05.002_bib25","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/art.21663","article-title":"Obstetric hospitalizations in the United States for women with systemic lupus erythematosus and rheumatoid arthritis","volume":"54","author":"Chakravarty","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.05.002_bib26","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3109\/03009742.2015.1013982","article-title":"Maternal and foetal outcomes in pregnant systemic lupus erythematosus patients: an incident cohort from a stable referral population followed during 1990-2010","volume":"44","author":"Jakobsen","year":"2015","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.berh.2016.05.002_bib27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1017\/S0965539500000917","article-title":"Practical management of pregnancy in systemic lupus erythematosus","volume":"5","author":"Buchanan","year":"1993","journal-title":"Fetal Matern Med Rev"},{"key":"10.1016\/j.berh.2016.05.002_bib28","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1191\/096120301678646137","article-title":"Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study","volume":"10","author":"Levy","year":"2001","journal-title":"Lupus"},{"key":"10.1016\/j.berh.2016.05.002_bib29","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1177\/0961203315591027","article-title":"Impact of hydroxychloroquine on preterm delivery and intrauterine growth restriction in pregnant women with systemic lupus erythematosus: a descriptive cohort study","author":"Leroux","year":"2015","journal-title":"Lupus"},{"key":"10.1016\/j.berh.2016.05.002_bib30","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1002\/art.22159","article-title":"Hydroxychloroquine in lupus pregnancy","volume":"54","author":"Clowse","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.05.002_bib31","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/096120339400300304","article-title":"Pregnancy in systemic lupus erythematosus: a prospective study","volume":"3","author":"Derksen","year":"1994","journal-title":"Lupus"},{"key":"10.1016\/j.berh.2016.05.002_bib32","doi-asserted-by":"crossref","first-page":"153","DOI":"10.7326\/M14-2235","article-title":"Predictors of pregnancy outcomes in patients with lupus: a cohort study","volume":"163","author":"Buyon","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.berh.2016.05.002_bib33","first-page":"1","article-title":"Pregnancies in women with systemic lupus erythematosus and antiphospholipid antibodies","author":"Schreiber","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.berh.2016.05.002_bib34","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.2215\/CJN.00240110","article-title":"A\u00a0systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis","volume":"5","author":"Smyth","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.berh.2016.05.002_bib35","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.berh.2016.05.002_bib36","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","article-title":"International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop","volume":"42","author":"Wilson","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.05.002_bib37","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0140-6736(93)91477-4","article-title":"The antiphospholipid syndrome: ten years on","volume":"342","author":"Hughes","year":"1993","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.berh.2016.05.002_bib38","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1055\/s-0028-1082270","article-title":"Lupus and the antiphospholipid syndrome in pregnancy and obstetrics: clinical characteristics, diagnosis, pathogenesis, and treatment","volume":"34","author":"Tincani","year":"2008","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.berh.2016.05.002_bib39","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1093\/rheumatology\/ker139","article-title":"Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study","volume":"50","author":"Ruffatti","year":"2011","journal-title":"Rheumatol (Oxford)"},{"key":"10.1016\/j.berh.2016.05.002_bib40","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/acr.20098","article-title":"Laboratory and clinical features of pregnant women with antiphospholipid syndrome and neonatal outcome","volume":"62","author":"Ruffatti","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.berh.2016.05.002_bib41","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jri.2006.12.003","article-title":"The obstetric antiphospholipid syndrome","volume":"77","author":"Derksen","year":"2008","journal-title":"J\u00a0Reprod Immunol"},{"key":"10.1016\/j.berh.2016.05.002_bib42","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.thromres.2004.08.005","article-title":"Antiphospholipid antibodies and fetal compromise","author":"Branch","year":"2004","journal-title":"Thrombosis Res"},{"key":"10.1016\/j.berh.2016.05.002_bib43","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/0961203309347794","article-title":"Pregnancy outcome in different clinical phenotypes of antiphospholipid syndrome","volume":"19","author":"Bramham","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.berh.2016.05.002_bib44","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1002\/art.34402","article-title":"Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies","volume":"64","author":"Lockshin","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.05.002_bib45","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/00006250-200212000-00032","article-title":"Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment","volume":"100","author":"Farquharson","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.berh.2016.05.002_bib46","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1097\/AOG.0b013e3181deba40","article-title":"Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss: a systematic review and meta-analysis","volume":"115","author":"Ziakas","year":"2010","journal-title":"Obs Gynecol"},{"key":"10.1016\/j.berh.2016.05.002_bib47","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/rheumatology\/kep373","article-title":"Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression","volume":"49","author":"Mak","year":"2010","journal-title":"Rheumatol (Oxford)"},{"key":"10.1016\/j.berh.2016.05.002_bib48","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ogc.2010.02.004","article-title":"Thromboprophylaxis in pregnancy: who and how?","volume":"37","author":"Davis","year":"2010","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.berh.2016.05.002_bib49","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1160\/th15-06-0491","article-title":"The efficacy of hydroxychloroquine in altering pregnancy outcome in women with antiphospholipid antibodies. Evidence and clinical judgment","volume":"115","author":"Sciascia","year":"2015","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.berh.2016.05.002_bib50","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10787-015-0239-y","article-title":"Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases","volume":"23","author":"Rainsford","year":"2015","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.berh.2016.05.002_bib51","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/art.22773","article-title":"Measuring disease activity and functionality during pregnancy in patients with rheumatoid arthritis","volume":"57","author":"de Man","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.05.002_bib52","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/art.24003","article-title":"Disease activity of rheumatoid arthritis during pregnancy: results from a nationwide prospective study","volume":"59","author":"de Man","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.05.002_bib53","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1002\/art.24914","article-title":"Association of higher rheumatoid arthritis disease activity during pregnancy with lower birth weight: results of a national prospective study","volume":"60","author":"De Man","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.05.002_bib54","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.3899\/jrheum.140583","article-title":"Disease severity and pregnancy outcomes in women with rheumatoid arthritis: results from the organization of teratology information specialists autoimmune diseases in pregnancy project","volume":"42","author":"Bharti","year":"2015","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2016.05.002_bib55","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1001\/jama.1976.03260280013012","article-title":"Letter: Raynaud phenomenon in pregnancy","volume":"235","author":"Cook","year":"1976","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.berh.2016.05.002_bib56","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1097\/01.AOG.0000308710.86880.a6","article-title":"Pregnancy outcomes in systemic sclerosis, primary pulmonary hypertension, and sickle cell disease","volume":"111","author":"Chakravarty","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.berh.2016.05.002_bib57","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/1529-0131(199904)42:4<763::AID-ANR21>3.0.CO;2-V","article-title":"Fertility and pregnancy outcome in women with systemic sclerosis","volume":"42","author":"Steen","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.05.002_bib58","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1002\/art.34350","article-title":"Brief report: successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: an Italian multicenter study","volume":"64","author":"Taraborelli","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.05.002_bib59","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee","volume":"23","author":"ARA Subcommittee","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.05.002_bib60","first-page":"1573","article-title":"Criteria for the classification of early systemic sclerosis","volume":"28","author":"LeRoy","year":"2001","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2016.05.002_bib61","series-title":"Contraception and pregnancy in patients with rheumatic disease","first-page":"185","article-title":"Myositis and pregnancy","author":"Di Martino","year":"2014"},{"key":"10.1016\/j.berh.2016.05.002_bib62","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.semarthrit.2014.05.004","article-title":"Pregnancy in adult-onset idiopathic inflammatory myopathy\u2019: report from a cohort of myositis patients from a single center","volume":"44","author":"Pinal-Fernandez","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.05.002_bib63","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.berh.2016.05.002_bib64","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis (second of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.berh.2016.05.002_bib65","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2147\/CLEP.S47399","article-title":"The epidemiology of Sj\u00f6gren's syndrome","author":"Shahane","year":"2014","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.berh.2016.05.002_bib66","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1093\/rheumatology\/ker077","article-title":"Pregnancy and fetal outcome in women with primary Sjogren's syndrome compared with women in the general population: a nested case-control study","volume":"50","author":"Hussein","year":"2011","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2016.05.002_bib67","first-page":"83","article-title":"Sj\u00f6gren\u2019s syndrome and pregnancy","volume":"16","author":"Takaya","year":"1991","journal-title":"Tokai J Exp Clin Med"},{"key":"10.1016\/j.berh.2016.05.002_bib68","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0735-1097(00)01048-2","article-title":"Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela","volume":"37","author":"Moak","year":"2001","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.berh.2016.05.002_bib69","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1161\/hc0702.104182","article-title":"Maternal anti-Ro and anti-La antibody - associated endocardial fibroelastosis","volume":"105","author":"Nield","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.berh.2016.05.002_bib70","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1002\/art.1780360911","article-title":"Identification of mothers at risk for congenital heart block and other neonatal lupus syndromes in their children: comparison of enzyme-linked immunosorbent assay and immunoblot for measurement of anti-SS-A\/Ro and anti- SS-B\/La antibodies","volume":"36","author":"Buyon","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.05.002_bib71","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0735-1097(01)01697-7","article-title":"Outcome of children with fetal, neonatal or childhood diagnosis of isolated congenital atrioventricular block: a single institution's experience of 30 years","volume":"39","author":"Jaeggi","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.berh.2016.05.002_bib72","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1177\/0961203315624024","article-title":"Autoimmune congenital heart block: complex and unusual situations","volume":"25","author":"Brito-Zer\u00f3n","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.berh.2016.05.002_bib73","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1191\/0961203302lu252oa","article-title":"Pregnancy outcome in 100 women with autoimmune diseases and anti-Ro\/SSA antibodies: a prospective controlled study","volume":"11","author":"Brucato","year":"2002","journal-title":"Lupus"},{"key":"10.1016\/j.berh.2016.05.002_bib74","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/S0735-1097(98)00161-2","article-title":"Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry","volume":"31","author":"Buyon","year":"1998","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.berh.2016.05.002_bib75","first-page":"36","article-title":"A\u00a0review of congenital heart block","volume":"5","author":"Friedman","year":"2003","journal-title":"Images Paediatr Cardiol"},{"key":"10.1016\/j.berh.2016.05.002_bib76","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.amjcard.2008.12.027","article-title":"Prospective evaluation of fetuses with autoimmune-associated congenital heart block followed in the PR interval and dexamethasone evaluation (PRIDE) study","volume":"103","author":"Friedman","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.berh.2016.05.002_bib77","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1161\/CIRCULATIONAHA.111.033894","article-title":"Maternal and fetal factors associated with mortality and morbidity in a multi-racial\/ethnic registry of anti-SSA\/Ro-associated cardiac neonatal lupus","volume":"124","author":"Izmirly","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.berh.2016.05.002_bib78","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1161\/CIRCULATIONAHA.111.041970","article-title":"Isolated atrioventricular block in the fetus: a retrospective, multinational, multicenter study of 175 patients","volume":"124","author":"Eliasson","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.berh.2016.05.002_bib79","first-page":"208311","article-title":"Assessment of fluorinated steroids to avert progression and mortality in anti-SSA\/Ro-associated cardiac injury limited to the fetal conduction system","author":"Izmirly","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2016.05.002_bib80","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/CIRCULATIONAHA.111.089268","article-title":"Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA\/ro-antibody - associated cardiac manifestations of neonatal lupus","volume":"126","author":"Izmirly","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.berh.2016.05.002_bib81","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/CRD.0000000000000026","article-title":"Prevention and treatment in utero of autoimmune-associated congenital heart block","volume":"22","author":"Saxena","year":"2014","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.berh.2016.05.002_bib82","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jacc.2010.09.044","article-title":"Use of intravenous gamma globulin and corticosteroids in the treatment of maternal autoantibody-mediated cardiomyopathy","volume":"57","author":"Trucco","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.berh.2016.05.002_bib83","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/art.27317","article-title":"Intravenous immunoglobulin does not prevent recurrence of congenital heart block in children of SSA\/Ro-positive mothers","volume":"62","author":"\u00d8Stensen","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.05.002_bib84","doi-asserted-by":"crossref","first-page":"D42","DOI":"10.1016\/j.jacc.2013.10.032","article-title":"Definitions and diagnosis of pulmonary hypertension","volume":"62","author":"Hoeper","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.berh.2016.05.002_bib85","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1093\/eurheartj\/ehr218","article-title":"ESC Guidelines on the management of cardiovascular diseases during pregnancy","volume":"32","author":"Regitz-Zagrosek","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.berh.2016.05.002_bib86","first-page":"943490","article-title":"Understanding and managing pregnancy in patients with lupus","volume":"2015","author":"de Jesus","year":"2015","journal-title":"Autoimmune Dis"},{"key":"10.1016\/j.berh.2016.05.002_bib87","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/1529-0131(199805)41:5<831::AID-ART9>3.0.CO;2-1","article-title":"Risk factors for ovarian failure in patients with systemic lupus erythematosus receiving cyclophosphamide therapy","volume":"41","author":"Mok","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.05.002_bib88","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1002\/art.10461","article-title":"Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide","volume":"46","author":"Houssiau","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.05.002_bib89","first-page":"1508","article-title":"Tolerability of mycophenolate mofetil in patients with systemic lupus erythematosus","volume":"30","author":"Riskalla","year":"2003","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2016.05.002_bib90","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa043731","article-title":"Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis","volume":"353","author":"Ginzler","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.berh.2016.05.002_bib91","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3109\/09513590.2011.650752","article-title":"Adjunctive GnRH-a treatment attenuates depletion of ovarian reserve associated with cyclophosphamide therapy in premenopausal SLE patients","volume":"28","author":"Marder","year":"2012","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.berh.2016.05.002_bib92","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1002\/art.21263","article-title":"Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus","volume":"52","author":"Somers","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.05.002_bib93","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1056\/NEJMsa1506575","article-title":"Declines in unintended pregnancy in the United States, 2008-2011","volume":"374","author":"Finer","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.berh.2016.05.002_bib94","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0272-6386(12)81115-2","article-title":"Maternal and fetal complications in pregnant women with systemic lupus erythematosus","volume":"17","author":"Hayslett","year":"1991","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.berh.2016.05.002_bib95","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/ncprheum0484","article-title":"Therapy insight: guidelines for selection of contraception in women with rheumatic diseases","volume":"3","author":"Sammaritano","year":"2007","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.berh.2016.05.002_bib96","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1136\/ard.2008.093013","article-title":"Risk and protective factors for thrombosis in systemic lupus erythematosus: results from a large, multi-ethnic cohort","volume":"68","author":"Kaiser","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2016.05.002_bib97","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1056\/NEJMoa051135","article-title":"Combined oral contraceptives in women with systemic lupus erythematosus","volume":"353","author":"Petri","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.berh.2016.05.002_bib98","series-title":"U.S. medical eligibility criteria for contraceptive use, 2010: adapted from the World Health Organization medical eligibility criteria for contraceptive use","first-page":"1","volume":"vol. 59(RR04)","author":"CDC","year":"2010"},{"key":"10.1016\/j.berh.2016.05.002_bib99","first-page":"1","article-title":"The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation","author":"Skorpen","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2016.05.002_bib100","article-title":"BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids","volume":"kev404","author":"Flint","year":"2016","journal-title":"Rheumatol (Oxford)"},{"key":"10.1016\/j.berh.2016.05.002_bib101","article-title":"BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part II: analgesics and other drugs used in rheumatology practice","volume":"kev405","author":"Flint","year":"2016","journal-title":"Rheumatol (Oxford)"},{"key":"10.1016\/j.berh.2016.05.002_bib102","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/ar1957","article-title":"Anti-inflammatory and immunosuppressive drugs and reproduction","volume":"8","author":"\u00d8stensen","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.berh.2016.05.002_bib103","series-title":"Chapter 36 \u2013 pregnancy in women with SLE","author":"Clowse","year":"2013"},{"key":"10.1016\/j.berh.2016.05.002_bib104","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1046\/j.1365-2265.1997.1230939.x","article-title":"Placental 11 beta-hydroxysteroid dehydrogenase: a key regulator of fetal glucocorticoid exposure","volume":"46","author":"Benediktsson","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.berh.2016.05.002_bib105","doi-asserted-by":"crossref","first-page":"6948","DOI":"10.1182\/blood-2011-02-339234","article-title":"First-trimester low-dose prednisolone in refractory antiphospholipid antibody-related pregnancy loss","volume":"117","author":"Bramham","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.berh.2016.05.002_bib106","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/BOR.0000000000000054","article-title":"Non-steroidal anti inflammatory drugs, glucocorticoids and disease modifying anti-rheumatic drugs for the management of rheumatoid arthritis before and during pregnancy","volume":"26","author":"Bermas","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.berh.2016.05.002_bib107","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/1096-9926(200012)62:6<385::AID-TERA5>3.0.CO;2-Z","article-title":"Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies","volume":"62","author":"Park-Wyllie","year":"2000","journal-title":"Teratology"},{"key":"10.1016\/j.berh.2016.05.002_bib108","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1056\/NEJM199101173240303","article-title":"A\u00a0randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group","volume":"324","author":"Bykerk","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.berh.2016.05.002_bib109","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.reprotox.2013.04.005","article-title":"Pregnancy outcome following in utero exposure to hydroxychloroquine: a prospective comparative observational study","volume":"39","author":"Diav-Citrin","year":"2013","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.berh.2016.05.002_bib110","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1002\/art.10150","article-title":"Evidence of transplacental passage of hydroxychloroquine in humans","volume":"46","author":"Costedoat-Chalumeau","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.05.002_bib111","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1002\/art.11304","article-title":"Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group","volume":"48","author":"Costedoat-Chalumeau","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.05.002_bib112","first-page":"1","article-title":"Breastfeeding in mothers with systemic lupus erythematosus","author":"Noviani","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.berh.2016.05.002_bib113","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1546-0096-7-9","article-title":"Systematic review of hydroxychloroquine use in pregnant patients with autoimmune diseases","volume":"7","author":"Sperber","year":"2009","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.berh.2016.05.002_bib114","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3109\/03009742.2011.626442","article-title":"Outcomes after anti-rheumatic drug use before and during pregnancy: a cohort study among 150 000 pregnant women and expectant fathers","volume":"41","author":"Viktil","year":"2012","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.berh.2016.05.002_bib115","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.reprotox.2007.11.010","article-title":"Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: a meta-analysis","volume":"25","author":"Rahimi","year":"2008","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.berh.2016.05.002_bib116","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/aje\/153.10.961","article-title":"Neural tube defects in relation to use of folic acid antagonists during pregnancy","volume":"153","author":"Hern\u00e1ndez-D\u00edaz","year":"2001","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.berh.2016.05.002_bib117","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1055\/s-2007-985612","article-title":"Advances in immunosuppressive therapy","volume":"28","author":"Marder","year":"2007","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.berh.2016.05.002_bib118","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1136\/gutjnl-2012-303615","article-title":"Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease","volume":"63","author":"Jharap","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.berh.2016.05.002_bib119","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1053\/j.gastro.2015.12.003","article-title":"The Toronto consensus statements for the management of inflammatory bowel disease in pregnancy","volume":"150","author":"Nguyen","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.berh.2016.05.002_bib120","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0022-3476(84)80435-7","article-title":"Neonatal pancytopenia and severe combined immunodeficiency associated with antenatal administration of azathioprine and prednisone","volume":"105","author":"DeWitte","year":"1984","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.berh.2016.05.002_bib121","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0022-3476(74)80109-5","article-title":"Effects on the neonate of prednisone and azathioprine administered to the mother during pregnancy","volume":"85","author":"Cot\u00e9","year":"1974","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.berh.2016.05.002_bib122","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/j.1572-0241.2007.01216.x","article-title":"Therapeutic drug use in women with Crohn's disease and birth outcomes: a Danish nationwide cohort study","volume":"102","author":"N\u00f8rg\u00e5rd","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.berh.2016.05.002_bib123","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.reprotox.2003.10.014","article-title":"Review of the potential effects of three commonly used antineoplastic and immunosuppressive drugs (cyclophosphamide, azathioprine, doxorubicin on the embryo and placenta)","volume":"18","author":"Matalon","year":"2004","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.berh.2016.05.002_bib124","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/bdra.20399","article-title":"Pregnancy outcome of women exposed to azathioprine during pregnancy","volume":"79","author":"Goldstein","year":"2007","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.berh.2016.05.002_bib125","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/acr.21888","article-title":"In utero azathioprine exposure and increased utilization of special educational services in children born to mothers with systemic lupus erythematosus","volume":"65","author":"Marder","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.berh.2016.05.002_bib126","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1177\/0961203314540353","article-title":"Tacrolimus is an effective treatment for lupus nephritis in pregnancy","volume":"23","author":"Webster","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.berh.2016.05.002_bib127","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3109\/s10165-010-0340-4","article-title":"Successful management of systemic lupus erythematosus nephritis flare-up during pregnancy with tacrolimus","volume":"21","author":"Alsuwaida","year":"2011","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.berh.2016.05.002_bib128","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2215\/CJN.06400612","article-title":"Breastfeeding and tacrolimus: serial monitoring in breast-fed and bottle-fed infants","volume":"8","author":"Bramham","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.berh.2016.05.002_bib129","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.trre.2008.05.001","article-title":"Pregnancy after transplantation","volume":"22","author":"Armenti","year":"2008","journal-title":"Transpl Rev"},{"key":"10.1016\/j.berh.2016.05.002_bib130","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/mpo.2950160102","article-title":"Long-term follow-up of children born to mothers with acute leukemia during pregnancy","volume":"16","author":"Avil\u00e9s","year":"1988","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.berh.2016.05.002_bib131","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ajh.2830360404","article-title":"Growth and development of children of mothers treated with chemotherapy during pregnancy: current status of 43 children","volume":"36","author":"Avil\u00e9s","year":"1991","journal-title":"Am J Hematol"},{"key":"10.1016\/j.berh.2016.05.002_bib132","first-page":"688","article-title":"Prospectively-followed pregnancies in patients with inflammatory arthritis taking bimological drugs: an Italian multicentre study","volume":"33","author":"Bazzani","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.berh.2016.05.002_bib133","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.cgh.2012.11.011","article-title":"Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease","volume":"11","author":"Mahadevan","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.berh.2016.05.002_bib134","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1586\/1744666X.2015.1037742","article-title":"Psoriasis during pregnancy: characteristics and important management recommendations","volume":"11","author":"Hoffman","year":"2015","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.berh.2016.05.002_bib135","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1093\/rheumatology\/keq185","article-title":"Etanercept concentrations in maternal serum, umbilical cord serum, breast milk and child serum during breastfeeding","volume":"49","author":"Berthelsen","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2016.05.002_bib136","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3899\/jrheum.080545","article-title":"A\u00a0safety assessment of tumor necrosis factor antagonists during pregnancy: a review of the food and drug administration database","volume":"36","author":"Carter","year":"2009","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2016.05.002_bib137","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.3899\/jrheum.090141","article-title":"Was risk properly assessed in Carter, et\u00a0al's safety assessment of tumor necrosis factor antagonists during pregnancy?","volume":"36","author":"Winger","year":"2009","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2016.05.002_bib138","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.3748\/wjg.v19.i17.2591","article-title":"Tumor necrosis factor-\u03b1 inhibitor therapy and fetal risk: a systematic literature review","volume":"19","author":"Marchioni","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.berh.2016.05.002_bib139","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/1741-7015-11-174","article-title":"Safety of TNF-\u03b1 inhibitors during IBD pregnancy: a systematic review","volume":"11","author":"Nielsen","year":"2013","journal-title":"BMC Med"},{"key":"10.1016\/j.berh.2016.05.002_bib140","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.crohns.2010.05.001","article-title":"Case report: fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's disease","volume":"4","author":"Cheent","year":"2010","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.berh.2016.05.002_bib141","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0889-857X(05)70320-3","article-title":"Immunosuppressive drug use during pregnancy","volume":"23","author":"Ramsey-Goldman","year":"1997","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.berh.2016.05.002_bib142","unstructured":"Sanofi. Arava & Pregnancy: Counseling guidelines for women of childbearing potential. http:\/\/www.arava.com\/hcp\/about\/pregnancy.aspx [accessed 01.04.16]."},{"key":"10.1016\/j.berh.2016.05.002_bib143","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/art.27358","article-title":"Birth outcomes in women who have taken leflunomide during pregnancy","volume":"62","author":"Chambers","year":"2010","journal-title":"Arthritis Rheum"}],"updated-by":[{"DOI":"10.1016\/j.berh.2020.101490","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000}}],"container-title":["Best Practice &amp; Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694216300262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694216300262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:16:19Z","timestamp":1761498979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694216300262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":143,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S1521694216300262"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2016.05.002","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pregnancy and autoimmune connective tissue diseases","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2016.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}